Reduced pupil diameter in volunteers on stable buprenorphine maintenance therapy with telaprevir: a drug-drug interaction involving p-glycoprotein at the blood-brain barrier?

Antimicrob Agents Chemother. 2012 Nov;56(11):6070. doi: 10.1128/AAC.01295-12.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Buprenorphine / pharmacokinetics*
  • Buprenorphine / therapeutic use*
  • Female
  • Humans
  • Male
  • Naloxone / pharmacokinetics*
  • Naloxone / therapeutic use*
  • Oligopeptides / pharmacokinetics*
  • Oligopeptides / therapeutic use*

Substances

  • Oligopeptides
  • Naloxone
  • Buprenorphine